• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. 3DKNEE; FEMUR, NONPOROUS, 3D, SIZE4, RT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. 3DKNEE; FEMUR, NONPOROUS, 3D, SIZE4, RT Back to Search Results
Model Number 233-02-104
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 02/19/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The reason for this revision surgery was due to instability.The previous surgery and the revision detailed in this investigation occurred over 1 year and 10 months apart.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.This investigation is limited in scope as limited information was provided to djo surgical - (b)(4) for examination and the part associated with this investigation was not returned to djo surgical for review.A review of the implant device history records (dhr) shows that the reported components used in the previous surgery met design and manufacturing requirements.There were no non-conforming material reports associated with the product that may have contributed to the event.The device and its applicable concomitant devices were within their respective expiration dates at the time of use during the previous surgery.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The root cause of this complaint was a revision surgery due to instability.There are multiple factors that may contribute to the event that are outside the control of djo surgical are poor bone density, inadequate soft tissue support, patient bone deterioration, degenerative bone, patient activities or trauma.No additional information was submitted with the complaint regarding pre-existing conditions of the patient or any activities that may have contributed to the event and hence a definitive root cause cannot be determined.There were no findings during this investigation that indicate that the reported device was the source or had a direct connection with the patient's event.There are no indications of a product or process issue affecting implant safety or effectiveness.
 
Event or Problem Description
Revision surgery - due to the patient's knee becoming unstable as per the doctor.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
3DKNEE
Common Device Name
FEMUR, NONPOROUS, 3D, SIZE4, RT
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin TX 78758 5445
MDR Report Key8430492
Report Number1644408-2019-00195
Device Sequence Number1664533
Product Code MBH
UDI-Device Identifier00888912111218
UDI-Public(01)00888912111218
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K032905
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 03/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/06/2023
Device Model Number233-02-104
Device Catalogue Number233-02-104
Device Lot Number903A1270
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/19/2019
Initial Report FDA Received Date03/18/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age56 YR
-
-